By annette
It builds on IHE’s leading expertise in the area of access to cancer medicines. The paper examines various aspects of inequalities in access to cancer medicines, covering key stages in a medicine’s life cycle, from marketing authorization to reimbursement decisions and uptake in clinical practice. It also explores potential strategies to stimulate competition among oncology …
By annette
IHE has during the last two years published several policy reports on breast cancer in different geographic regions of the world, and more recently another report on endometrial cancer. At the World Cancer Congress 2024, IHE’s Thomas Hofmarcher participates in a panel discussion on health literacy in women’s cancers pathways. An upcoming report by Dr. …
By annette
At the ESMO Congress 2024, Thomas Hofmarcher will present IHE’s latest report on endometrial cancer. The presentation is part of the session called “Improving the experience of care for women with gynaecological cancers: Lessons from cervical and endometrial cancer policy”, hosted by EONS – European Oncology Nursing Society. Thomas’ presentation will provide a broad overview …
By annette
Some 90% of all cancers originating in the body of the uterus (corpus uteri) are classified as endometrial cancer. It is the most common gynecological cancer in Europe and Northern America. Yet it receives less attention in the public discourse on cancer than cervical cancer and ovarian cancer. This report will provide a broad overview …
By annette
Precision medicine is often cited for its expected potential to revolutionise health care. This report reviews challenges to standard methods for cost-effectiveness analyses raised in health-economic and clinical oncology literature. It also discusses further considerations and challenges when estimating the value of precision medicine interventions. Read more and download the report
By annette
The Swedish Institute for Health Economics (IHE) and the Bengt Jönsson Foundation for Health Economics Research are hereby pleased to announce the recipient of the scholarship for this year’s student thesis in health economics. Read more
By annette
What is the current status of lung cancer care in Poland? This dashboard-style report provides a visual description of selected performance indicators in all areas of lung cancer care. The dashboard includes comparisons between voivodeships and with the Visegrád countries and the EU average. For every indicator, the dashboard gives recommendations to improve the status …
By annette
A new Swedish study from IHE reports on health-related quality of life in patients afflicted by palmoplantar pustulosis (PPP). Read more This study evaluated an add-on to standard of care (SoC) for reducing seizure frequency in Dravet syndrome. Read more
By annette
IHE is growing! We have welcomed two new colleagues after the summer: Ann-Louise Tidell as our new Chief Operating Manager and Ida Haggren as an Analyst. We have also welcomed Katarina Gralén back to IHE.
By annette
The medical treatment of lung cancer has undergone major changes in the last 15 years. The introduction of targeted therapy for multiple mutations and of immunotherapy for non-oncogene-addicted cases has altered the recommended treatment paradigm. While clinical trials have shown promising results of increased survival, real-world evidence is still scarce. IHE has entered into a …